Rs. 5,000-crore scheme invites applications from startups, MSMEs and industry across new medicines, biosimilars, novel medical devices and other priority areas
The union minister highlighted India's growing role in global healthcare and the potential of artificial intelligence (AI) to transform drug discovery, diagnostics and patient care
The conference provided a platform for knowledge sharing, networking and collaboration aimed at promoting a ‘whole-of-government’ approach and reducing organisational silos
Health Ministry reviews ILI/SARI trends, testing, hospital capacity and critical-care readiness in Delhi and across India
The state has has more than 20 dedicated life sciences incubators supporting over 1,000 startups, alongside research capabilities, global capability centres, manufacturing infrastructure and a deep talent pool
Calling for the creation of brands that attract the world, Modi said Indian brands should become a strong representation of the country and strengthen India’s identity as a global destination
New unified authority aims to strengthen regulatory oversight and enforcement under the Food Safety and Standards Act and Drugs and Cosmetics Act, as state moves to curb spurious and substandard products
The consultation brought together parliamentarians from both states across party lines and focused on strengthening political leadership, community participation and last-mile delivery of TB services
The event on August 21, 2026 has been designed to exchange best practices, discuss emerging workforce trends and contribute to shaping India’s national skilling agenda for the life sciences sector
The knowledge paper points to fragmented health data, limited clinical evidence and the absence of predictable lifecycle-based regulation for adaptive AI as key barriers to wider adoption
India Medical Device 2026 highlights the need for deeper domestic value addition, advanced manufacturing, predictable regulation and stronger industry-startup collaboration
ICMR, CSIR and DBT actively promoting and strengthening the use of advanced in-vitro, cell-based, three-dimensional tissue models and computational methods
The ministry has incorporated procedural safeguards, including the issuance of a show-cause notice before any debarment order is passed
Anil Matai, Director General, OPPI calls for structured and regular engagement between regulators and industry to strengthen trust, transparency, and collaboration within India’s pharma regulatory ecosystem
The country now ranks third globally in the total number of organ transplants after the United States and China though a significant gap remains between organ demand and availability
Recommendations were made at MTaI's closed-door roundtable organised as part of the association's 10th anniversary that brought together policymakers, diplomatic representatives from various embassies, along with trade experts and MedTech industry leaders
New platform aims to accelerate approvals, strengthen transparency and enhance global confidence in India's pharmaceutical regulatory system
After delayed environmental clearance, the project has now gained pace with around 20% of Phase-I site development completed, and nearly 98% of the 15 MLD water supply and groundwater recharge system completed
The drugs that received one time exemption to ease shortages include Carboplatin Injection (10 mg/ml), Cisplatin Injection (1 mg/ml), Anti-Tetanus Immunoglobulin 250 IU and Anti-Tetanus Immunoglobulin 500 IU
Union health minister JP Nadda to outline government's MedTech vision at DoP and FICCI’s flagship conference on August 7-8 in New Delhi
Subscribe To Our Newsletter & Stay Updated
